| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0140-6736(68)90591-6 |
| P698 | PubMed publication ID | 4173788 |
| P2093 | author name string | R A Cash | |
| R Islam | |||
| D R Nalin | |||
| M Molla | |||
| R A Phillips | |||
| P433 | issue | 7564 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cholera | Q12090 |
| P304 | page(s) | 370-373 | |
| P577 | publication date | 1968-08-01 | |
| P1433 | published in | The Lancet | Q939416 |
| P1476 | title | Oral maintenance therapy for cholera in adults | |
| P478 | volume | 2 |
| Q41680574 | "Feeding the gut": the scientific basis for continued enteral nutrition during acute diarrhea |
| Q91174712 | 50 years of oral rehydration therapy: the solution is still simple |
| Q70513270 | A comparison of oral replacement solutions containing sodium in concentrations of 120 m mols/L and 60 m mols/L in paediatric diarrhoea |
| Q34146796 | A legacy in 20th-century medicine: Robert Allan Phillips and the taming of cholera |
| Q36674936 | A study of oral rehydration therapy by midwives in a rural area near Ankara |
| Q70762701 | A study of oral rehydration therapy in childhood diarrhea |
| Q41844990 | Absorption of a hypotonic oral rehydration solution in a human model of cholera |
| Q40310088 | Actions of cholera toxin and the prevention and treatment of cholera |
| Q36904890 | Acute infectious pediatric gastroenteritis: beyond oral rehydration therapy |
| Q34213518 | Ad libitum oral glucose-electrolyte therapy for acute diarrhea in Apache children |
| Q28206581 | An evaluation of current cholera treatment |
| Q54546947 | Bangladesh's health revolution. |
| Q70114487 | Blood-groups and coronary heart-disease |
| Q55890255 | Cholera |
| Q71721493 | Cholera again |
| Q34377835 | Cholera and severe toxigenic diarrhoeas |
| Q42086052 | Cholera in Sudan: An account of an epidemic in a refugee camp in eastern Sudan, May–June 1985 |
| Q41890572 | Cholera--a clue to "functional diarrhoea"? |
| Q39499267 | Clinical and bacteriological studies of El Tor cholera after ingestion of known inocula in Thai volunteers |
| Q40813092 | Comparison of Sucrose and Glucose in the Oral Electrolyte Therapy of Cholera and Other Severe Diarrheas |
| Q39498427 | Comparison of sucrose with glucose in oral therapy of infant diarrhoea |
| Q34696164 | Congenital bowing of the long bones in two sisters |
| Q41148425 | Controlled trial of chlorpromazine as antisecretory agent in patients with cholera hydrated intravenously. |
| Q93770377 | Correspondence |
| Q37998392 | Deciphering the mechanisms of the Na+/H+ exchanger-3 regulation in organ dysfunction. |
| Q66699667 | Delivery pack for traditional birth attendants |
| Q36715302 | Diarrhoea case management in low- and middle-income countries--an unfinished agenda |
| Q34474390 | Diarrhoea: mechanisms and treatment |
| Q39568889 | Diarrhoeal mortality in two Bangladeshi villages with and without community-based oral rehydration therapy |
| Q68716011 | Effect of cholera toxin on small intestinal motor activity in the fed state |
| Q54378831 | Effect of composition of gastric contents on resistance to emptying of liquids from stomach in humans |
| Q35004655 | Effect of glycine and glucose on sodium and water absorption in patients with cholera |
| Q34119980 | Effects of intraluminal glucose on intestinal secretion induced by heat stable and heat labile Escherichia coli enterotoxin, cholera toxin and theophylline |
| Q40978140 | Electrolyte fluxes in the gut and oral rehydration solutions |
| Q70766993 | Electrolyte/glucose concentration and bacterial contamination in home-prepared oral rehydration solution: A field experience in northeastern Brazil |
| Q53385810 | Factors associated with safe preparation and home use of sugar-salt solution. |
| Q43317949 | Failure of oral glucose therapy in short-bowel syndrome |
| Q42027383 | Fluid therapy trials in neonatal piglets infected with transmissible gastroenteritis virus |
| Q48725442 | Gastric emptying of liquids in rats dehydrated by water deprivation |
| Q64969152 | HLA antigens and schizophrenia. |
| Q39567196 | History and rationale of oral rehydration and recent developments in formulating an optimal solution. |
| Q35603787 | Hydrolysed wheat based oral rehydration solution for acute diarrhoea |
| Q41593392 | Immunity of cholera in man: Relative role of antibacterial versus antitoxic immunity |
| Q44025339 | Inhibition by apple polyphenols of ADP-ribosyltransferase activity of cholera toxin and toxin-induced fluid accumulation in mice |
| Q53446130 | International research laboratory in Bangladesh. |
| Q44137642 | Introduction of ERAS(®) program into clinical practice: from preoperative management to postoperative evaluation : Opening remarks |
| Q39382384 | Letter: Oral rehydration in rural India |
| Q39363486 | Letter: Oral sucrose therapy for diarrhoea |
| Q36542194 | Letter: Oral sucrose therapy for diarroea |
| Q66704592 | Letter: Prenatal diagnosis of hypophosphatasia |
| Q39363479 | Letter: Success with lithium in a disturbed child |
| Q24516870 | Magic bullet: the history of oral rehydration therapy |
| Q93727721 | Management of thalassaemia |
| Q97870437 | Mapping geographical inequalities in oral rehydration therapy coverage in low-income and middle-income countries, 2000-17 |
| Q48292503 | Mechanism for control of prolactin secretion |
| Q40695423 | New developments in the understanding of cholera |
| Q48505512 | Norovirus Illnesses in Children and Adolescents. |
| Q36720036 | Oral (or nasogastric) maintenance therapy for cholera patients in all age-groups |
| Q41431109 | Oral Therapy for Diarrhoea |
| Q34202190 | Oral fluid therapy of Apache children with acute infectious diarrhoea |
| Q93705825 | Oral glucose in reduction of jejunostomy effluent |
| Q93815106 | Oral or nasogastric maintenance therapy in pediatric cholera patients |
| Q42121366 | Oral rehydration formula containing alanine and glucose for treatment of diarrhoea: a controlled trial |
| Q39567163 | Oral rehydration in infants in developing countries |
| Q39579054 | Oral rehydration of neonates with dehydrating diarrhoeas |
| Q24234259 | Oral rehydration salt solution for treating cholera: ≤ 270 mOsm/L solutions vs ≥ 310 mOsm/L solutions |
| Q45180303 | Oral rehydration therapy in infectious diarrhoea. Comparison of rehydration solutions with 60 and 90 mmol sodium per litre |
| Q50203454 | Oral rehydration therapy in malnourished infants with infectious diarrhoea |
| Q54396028 | Oral rehydration therapy of neonates. |
| Q66695116 | Oral therapy for diarrhoea |
| Q33565570 | Pharmacoeconomics of the therapy of diarrhoeal disease |
| Q38905455 | Pharmacy dispensing practices for Sudanese children with diarrhoea |
| Q44363980 | Preoperative fluid and electrolyte management with oral rehydration therapy |
| Q92574357 | Preventing cholera in India: Synthesizing evidences through a systematic review for policy discussion on the use of oral cholera vaccine |
| Q61445428 | Progress in the use of ORS and zinc for the treatment of childhood diarrhea |
| Q35169613 | Randomised double blind trial of single dose doxycycline for treating cholera in adults |
| Q67235522 | Rapid correction of acidosis and dehydration of cholera with oral electrolyte and glucose solution |
| Q72418285 | Realistic look at small, round faecal viruses found by electronmicroscopy |
| Q24245939 | Reduced osmolarity oral rehydration solution for treating cholera |
| Q36874863 | Replacement of intravenous therapy by oral rehydration solution in a large treatment centre for diarrhoea with dehydration |
| Q94181630 | Replacement of intravenous therapy by oral rehydration solution in a large treatment centre for diarrhoea with dehydration* |
| Q40183655 | Reversal of cyclic AMP-mediated intestinal secretion in mice by chlorpromazine |
| Q41554316 | Review of oral rehydration solutions for horses with diarrhoea |
| Q72528086 | Rice-powder electrolyte solution as oral-therapy in diarrhoea due to Vibrio cholerae and Escherichia coli |
| Q71832908 | Salt and water homeostasis during oral rehydration therapy |
| Q72891557 | Stool electrolyte content and purging rates in diarrhea caused by rotavirus, enterotoxigenic E. coli and V. cholerae in children |
| Q39333060 | Sucrose in oral therapy for cholera and related diarrhoeas |
| Q42713065 | The effect of amino acids and dipeptides on sodium and water absorption in man |
| Q33754483 | The effect of oral rehydration solution and recommended home fluids on diarrhoea mortality |
| Q34876417 | The molecular basis for control of ETEC enterotoxin expression in response to environment and host |
| Q41593317 | The problem of emesis during oral glucose-electrolytes therapy given from the onset of severe cholera |
| Q53442370 | The role of oral electrolyte-glucose solutions in hydration for children--international and domestic aspects. |
| Q39150682 | The use of oral replacement solutions in the treatment of choleraand other severe diarrhoeal disorders |
| Q71728503 | Treatment of 242 neonates with dehydrating diarrhea with an oral glucose-electrolyte solution |
| Q36411273 | Treatment of diarrhoea in Indonesian children: what it costs and who pays for it. |
| Q54736148 | Trial of clioquinol in cholera. |
| Q44844049 | Vaba, Haiza, Kholera, Foklune or Cholera: in any language still the disease of seven pandemics |
| Q45895770 | Vibration-assisted bladder emptying in multiple sclerosis |
| Q34562952 | Vibrio cholerae: lessons for mucosal vaccine design |
| Q72418288 | Village health education and oral diarrhoea therapy |
| Q34396418 | Water and solute absorption from a new hypotonic oral rehydration solution: evaluation in human and animal perfusion models |
| Q27486429 | Infectious diseases. Annual review of significant publications. |
Search more.